Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
China · Delayed Price · Currency is CNY 21.89
-0.48 (-2.15%)
At close: Sep 11, 2026
SHA:688443 Market Cap
SHA:688443 has a market cap or net worth of 8.03 billion as of September 11, 2026. Its market cap has decreased by -35.03% in one year.
Market Cap
8.03B
Enterprise Value
7.30B
Revenue
338.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
21.89
ChartMarket Cap Chart
Since June 20, 2023, SHA:688443's market cap has decreased from 12.47B to 8.03B, a decrease of -35.66%. That is a compound annual growth rate of -12.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 8.03B | -19.64% |
| Dec 31, 2025 | 9.99B | 8.57% |
| Dec 31, 2024 | 9.20B | -37.20% |
| Dec 29, 2023 | 14.65B | 17.43% |
| Jun 20, 2023 | 12.47B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shanghai OPM Biosciences | 9.07B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 8.86B |
| Vcanbio Cell & Gene Engineering Corp., | 8.22B |
| Liaoning Chengda Biotechnology | 8.16B |
| Chengdu Easton Biopharmaceuticals | 8.08B |
| Aurisco Pharmaceutical | 7.75B |
| Beijing Hotgen Biotech | 7.48B |
| Daan Gene | 7.41B |